The antihypertensive and lipid-lowering to prevent heart attack trial renewal

Ended Definitive Contract Awarded Last action

Contract number
HHSN268201100036C
Awardee
Awarding agency
Obligated
$4,209,368

Award facts

Opportunity
Contract value 100% obligated
$4,209,368.29 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Houston, TX 77030, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 13 -$115,333
Change Order 12 -$36,691
Funding Only Action 11 $1,012,341
Other Administrative Action 10 · Antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT) renewal -$5,300
Funding Only Action 9 $759,124
Other Administrative Action 8 $0
Other Administrative Action 7 · Allhat renewal $0
Funding Only Action 6 · Allhat renewal, 6/1/2013 to 5/31/2014 $650,259
Other Administrative Action 5 $0
Other Administrative Action 4 · Allhat renewal $0
Other Administrative Action 3 $0
Funding Only Action 2 · Other functions - allhat renewal $973,725
Other Administrative Action 1 · Antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT) renewal $0
Original award $971,242
Show all 14

About this award

This federal contract award for $4,209,368.29 was made by the National Heart Lung and Blood Institute, part of the National Institutes of Health, to the University of Texas Health Science Center at Houston (UTHealth). The contract, titled "THE ANTIHYPERTENSIVE AND LIPID-LOWERING TO PREVENT HEART ATTACK TRIAL RENEWAL", does not have a set-aside designation and is a definitive contract with a cost-no-fee pricing type. UTHealth is a subcomponent of the larger University of Texas System, which frequently receives federal contracts and grants to support its extensive biomedical and public health research activities. This specific contract supports a clinical trial focused on cardiovascular disease prevention, leveraging UTHealth's expertise in areas like neuroscience, cancer, and infectious diseases to advance medical knowledge and treatments.

Quick answers

Who was awarded contract HHSN268201100036C?

HHSN268201100036C was awarded to University Of Texas Health Science Center At Houston by National Heart Lung and Blood Institute (National Institutes of Health) on June 1, 2011.

How much is contract HHSN268201100036C worth?

The government has obligated $4,209,368 on HHSN268201100036C.

Was contract HHSN268201100036C competed?

The extent of competition for HHSN268201100036C was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award